Price $35.17 |
Market Cap
2.92B
|
Sector Health Care |
Div. Growth
-20.00%
|
|
P/E
13.9
|
P/B
2.2
|
P/S
0.42
|
Dividend %
2.20%
|
|
P/CF
419.3
|
P/FCF
24.0
|
Op. Cash Flow
393.1K
|
FCF
0.9
|
|
Op. Margin
7.50%
|
Net Margin
3.00%
|
ROE
16.90%
|
ROI
6.80%
|
|
ROA
2.60%
|
EPS Growth
-24.90%
|
Current Ratio
1.1
|
Debt/Equity
341.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
